» Articles » PMID: 34458013

The Role of SAXS and Molecular Simulations in 3D Structure Elucidation of a DNA Aptamer Against Lung Cancer

Abstract

Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as synthetic analogs of antibodies and bind to a target molecule with high specificity. Aptamer affinity entirely depends on its tertiary structure and charge distribution. Therefore, length and structure optimization are essential for increasing aptamer specificity and affinity. Here, we present a general optimization procedure for finding the most populated atomistic structures of DNA aptamers. Based on the existed aptamer LC-18 for lung adenocarcinoma, a new truncated LC-18 (LC-18t) aptamer LC-18t was developed. A three-dimensional (3D) shape of LC-18t was reported based on small-angle X-ray scattering (SAXS) experiments and molecular modeling by fragment molecular orbital or molecular dynamic methods. Molecular simulations revealed an ensemble of possible aptamer conformations in solution that were in close agreement with measured SAXS data. The aptamer LC-18t had stronger binding to cancerous cells in lung tumor tissues and shared the binding site with the original larger aptamer. The suggested approach reveals 3D shapes of aptamers and helps in designing better affinity probes.

Citing Articles

PD-L1 aptamer-functionalized degradable hafnium oxide nanoparticles for near infrared-II diagnostic imaging and radiosensitization.

Wei M, Shen X, Fan X, Li J, Bai J Front Bioeng Biotechnol. 2023; 11:1224339.

PMID: 37351473 PMC: 10282151. DOI: 10.3389/fbioe.2023.1224339.


Analysis of aptamer-target binding and molecular mechanisms by thermofluorimetric analysis and molecular dynamics simulation.

Zhang H, Lv C, Li Z, Jiang S, Cai D, Liu S Front Chem. 2023; 11:1144347.

PMID: 37228865 PMC: 10204870. DOI: 10.3389/fchem.2023.1144347.


Discovery of DNA aptamers targeting SARS-CoV-2 nucleocapsid protein and protein-binding epitopes for label-free COVID-19 diagnostics.

Poolsup S, Zaripov E, Huttmann N, Minic Z, Artyushenko P, Shchugoreva I Mol Ther Nucleic Acids. 2023; 31:731-743.

PMID: 36816615 PMC: 9927813. DOI: 10.1016/j.omtn.2023.02.010.


Successes and Failures of Static Aptamer-Target 3D Docking Models.

Bruno J Int J Mol Sci. 2022; 23(22).

PMID: 36430888 PMC: 9695435. DOI: 10.3390/ijms232214410.


An overview of structural approaches to study therapeutic RNAs.

Mollica L, Cupaioli F, Rossetti G, Chiappori F Front Mol Biosci. 2022; 9:1044126.

PMID: 36387283 PMC: 9649582. DOI: 10.3389/fmolb.2022.1044126.


References
1.
Carothers J, Oestreich S, Szostak J . Aptamers selected for higher-affinity binding are not more specific for the target ligand. J Am Chem Soc. 2006; 128(24):7929-37. PMC: 4287982. DOI: 10.1021/ja060952q. View

2.
Knight C, Hub J . WAXSiS: a web server for the calculation of SAXS/WAXS curves based on explicit-solvent molecular dynamics. Nucleic Acids Res. 2015; 43(W1):W225-30. PMC: 4489308. DOI: 10.1093/nar/gkv309. View

3.
Furtig B, Richter C, Wohnert J, Schwalbe H . NMR spectroscopy of RNA. Chembiochem. 2003; 4(10):936-62. DOI: 10.1002/cbic.200300700. View

4.
Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249(4968):505-10. DOI: 10.1126/science.2200121. View

5.
Ellington A, Szostak J . In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346(6287):818-22. DOI: 10.1038/346818a0. View